###begin article-title 0
###xml 53 72 53 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 53 71 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
Infection by and protective immune responses against Plasmodium berghei ANKA are not affected in macrophage scavenger receptors A deficient mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 141 145 <span type="species:ncbi:10090">Mice</span>
Scavenger receptors (SRs) recognize endogenous molecules modified by pathological processes as well as components of diverse microorganisms. Mice deficient for both SR-AI and II are more susceptible to infections by a variety of bacterial and viral pathogens.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
Here we show that SR-A deficient mice and wild type mice are equally susceptible to malaria infection both during liver and blood stages. Moreover, like wild type mice, SR-A deficient mice are able to mount a protective immune response against radiation attenuated sporozoites.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 71 90 71 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 71 89 <span type="species:ncbi:5821">Plasmodium berghei</span>
Our results do not reveal a function of SR-A I and II receptors in the Plasmodium berghei ANKA infection, both in the development of CM and parasitemia control. Moreover, these receptors appear not to be required for the establishment of a protective immune response against the malaria liver stages.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 69 80 69 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 569 577 <span type="species:ncbi:9606">children</span>
Malaria infection starts in the mammalian host with the injection of Plasmodium sporozoites by a mosquito bite. Sporozoites travel to the liver where they cross the sinusoidal wall through Kupffer cells and then migrate through several hepatocytes before they establish an infection with the formation of a parasitophorous vacuole [1,2]. Within the vacuole the sporozoites develop and generate millions of merozoites that are released into the bloodstream. With the infection of erythrocytes the clinical phase of malaria begins. In any given year, more than a million children die as a result of malaria infection. The death from infection is largely due to an acute syndrome known as cerebral malaria (CM). The neurological manifestations of CM include headache, agitation, psychosis, seizures and impaired consciousness that lead to coma and death [3].
###end p 9
###begin p 10
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 739 740 739 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 858 859 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 965 966 965 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1024 1025 1024 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1137 1138 1137 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1183 1186 1183 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1273 1296 1273 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listeria monocytogenes </italic>
###xml 1297 1298 1297 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1301 1323 1301 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 1324 1325 1324 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1328 1353 1328 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus Calmette-Gu&#233;rin </italic>
###xml 1354 1356 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1384 1385 1384 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
###xml 1273 1295 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 1301 1322 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 1328 1352 <span type="species:ncbi:33892">Bacillus Calmette-Guerin</span>
The class A macrophage scavenger receptor (SR-A) is the prototypic member of a large family of membrane receptors that bind oxidized low density lipoprotein and a wide variety of other ligands many of which are derived from apoptotic cells and pathogens [4]. The SR-A receptors occur in two different forms that are generated by alternative splicing of the primary transcript: SR-AI and SR-AII. Both receptors have nearly identical ligand binding properties [4]. They are expressed primarily by mature cells of the myelomonocytic lineage such as Kupffer cells in the liver, glial cells in the brain and macrophages that are resident in or recruited to various tissues. They are also expressed by sinusoidal endothelial cells in the liver [5]. SR-A receptors appear to have beneficial and pathological functions. They mediate phagocytosis of apoptotic cells [6], and have been implicated in atherogenesis, the clearance of debris during acute neuronal degeneration [7] as well as in innate immunity and antigen presentation [6]. SR-A receptors bind lipopolysaccharide from Gram-negative and lipoteichoic acid from Gram-positive bacteria [4]. SR-AI and II receptor deficient mice (SR-A-/-) are more susceptible to infections by a variety of pathogenic microorganisms such as Listeria monocytogenes [8], Staphylococcus aureus [9], Bacillus Calmette-Guerin [10] and herpes simplex virus [8].
###end p 10
###begin p 11
In the present work we examined the role of SR-A receptors in three different aspects of a malaria infection, namely first, in the establishment of a primary liver infection; second, in the protective immune response against the liver stages; and third, in the development of the cerebral pathology associated with blood stages of infection.
###end p 11
###begin title 12
Results and discussion
###end title 12
###begin p 13
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 297 301 297 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 327 331 327 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 360 379 360 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 629 648 629 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 709 728 709 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 750 754 750 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 781 785 781 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 360 378 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 629 647 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 709 727 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 754 758 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
The initial targeting of sporozoites to the liver involves close interactions with sinusoidal endothelial cells and Kupffer cells [2], both of which express SR-AI and SR-AII receptors. To study the possible involvement of these receptors in the initial stages of malaria infection we infected SR-A-/- mice as well as their SR-A+/+ littermates [8] with 2 x 104 Plasmodium berghei ANKA sporozoites. The parasite burden in the liver was measured 40 hours after infection, just prior to the release of merozoites into the bloodstream. The level of infection was determined by quantitative RT-PCR (qRT-PCR) using specific primers for Plasmodium berghei 18s ribosomal RNA [11]. There was no difference in the level Plasmodium berghei ANKA infection in SR-A-/- mice, when compared to SR-A+/+ mice (Fig. 1A).
###end p 13
###begin p 14
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 598 602 598 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 628 632 628 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 645 646 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 674 676 674 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 676 695 676 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 735 737 735 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 938 942 938 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1113 1117 1113 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 449 455 <span type="species:ncbi:9606">humans</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 676 694 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
SR-A receptor functions have been implicated in both the innate and the adaptive branches of the immune response. To determine whether SR-A receptors play a role in immune responses against malaria, we used a well-established model of immunization against the liver stages of malaria infection. Inoculation with radiation attenuated sporozoites (RAS) results in protection against a subsequent challenge with infective sporozoites, both in mice and humans [12,13]. Irradiated sporozoites invade hepatocytes but do not develop normally and thus fail to establish an erythrocytic infection [14]. SR-A-/- mice as well as their SR-A+/+ littermates [8] were immunized with 5 x 104 Plasmodium berghei RAS and challenged 10 days later with 104 infective sporozoites. Forty two hours after the challenge the level of protection was measured by quantifying the parasite load in the liver using qRT-PCR, as described above. RAS immunization of SR-A+/+ mice, as expected, clearly reduced the level of infection measured 40 hours after a challenge with infective sporozoites. The same level of protection was achieved in SR-A-/- mice (Fig. 1B). This shows that the lack of SR-A receptors does not affect the establishment of a protective immune response against RAS.
###end p 14
###begin p 15
###xml 614 633 614 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 720 739 720 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1065 1077 1065 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">reviewed in </italic>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1306 1317 1306 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei </italic>
###xml 1643 1647 1643 1647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1666 1670 1666 1670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1711 1713 1711 1713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 1713 1732 1713 1732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 1867 1869 1867 1869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1965 1967 1965 1967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 2035 2037 2035 2037 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 2166 2171 2166 2171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 2311 2330 2311 2330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 2383 2385 2383 2385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2422 2426 2422 2426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 2628 2632 2628 2632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2812 2822 2812 2822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. yoelii </italic>
###xml 2995 2999 2995 2999 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 3186 3191 3186 3191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 3194 3196 3194 3196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 614 632 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 720 738 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 988 993 <span type="species:ncbi:9606">human</span>
###xml 1163 1168 <span type="species:ncbi:9606">human</span>
###xml 1184 1189 <span type="species:ncbi:9606">human</span>
###xml 1279 1284 <span type="species:ncbi:10090">mouse</span>
###xml 1306 1316 <span type="species:ncbi:5821">P. berghei</span>
###xml 1513 1518 <span type="species:ncbi:9606">human</span>
###xml 1647 1651 <span type="species:ncbi:10090">mice</span>
###xml 1713 1731 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 1764 1768 <span type="species:ncbi:10090">mice</span>
###xml 2246 2250 <span type="species:ncbi:10090">mice</span>
###xml 2311 2329 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 2426 2430 <span type="species:ncbi:10090">mice</span>
###xml 2477 2481 <span type="species:ncbi:10090">mice</span>
###xml 2512 2516 <span type="species:ncbi:10090">mice</span>
###xml 2632 2636 <span type="species:ncbi:10090">mice</span>
###xml 2812 2821 <span type="species:ncbi:5861">P. yoelii</span>
###xml 2852 2856 <span type="species:ncbi:10090">mice</span>
The molecular and cellular mechanisms that lead to the devastating symptoms of CM remain poorly understood. The disease is associated with enhanced adherence of infected erythrocytes to the cerebral vasculature, disruption of the blood-brain barrier, activation and proliferation of migroglial cells, expression and secretion of proinflammatory molecules, and recruitment of macrophages and other inflammatory cells to the primary lesions. SR-AI and II receptors are expressed by both activated macrophages and glial cells. They could have disease promoting or protective functions. Infection of C57BL/6 mice with Plasmodium berghei ANKA is a well-established experimental model of malaria infection. When infected with Plasmodium berghei ANKA, C57BL/6 mice develop neurological disturbances such as hemi- or paraplegia, deviation of the head, tendency to roll over on stimulation, ataxia and convulsions and die between days 6 to 9 post-infection [15]. Due to the many similarities with human CM this neurological syndrome is referred to as experimental CM (ECM) (reviewed in [15]). Still, caution should be taken when extrapolating from the rodent model to the human disease. While human CM is predominantly associated with iRBC adherence to the microvasculature of the brain, mouse brains infected with P. berghei ANKA (and showing symptoms of ECM) show blood brain vessel congestion containing mainly leucocytes and low level of iRBCs. Despite these differences, the altered cells that play a pivotal role in human and rodent lesions during malaria infection are the same, the brain microvascular endothelial cells. We inoculated both SR-A-/- mice and their SR-A+/+ littermates in C57BL/6 background with 106 Plasmodium berghei ANKA infected erythrocytes. All mice in both groups developed neurological symptoms and died between 6 to 8 days after infection (Fig. 2A). There were no significant differences in the level of parasitemia between the 2 groups (Fig. 2B). The results were similar when infection was initiated with 2 x 104 sporozoites and allowed to proceed for blood stages (data not shown). This finding is in agreement with a short report by Nogami et al. who found the same levels of parasitemia in SR-A deficient and wild type mice after inoculation with erythrocytes that were infected with Plasmodium berghei NK65, an experimental model that does not induce CM [16]. In that study only 1 out of 8 SR-A+/+ mice died on day 10, while in the group 2 out of 8 mice died on day 7 and a further 3 mice died on day 17. Since these deaths coincided with the two peaks of parasitemia, the authors suggested that SR-A-/- mice might have more difficulty in controlling peaks of parasitemia. Thus, we sought to determine the role of SR-A in the course of infection of a non-lethal malaria rodent model, P. yoelii 17x. In this model, wild-type mice produce a peak of parasitemia around day 10 post-infection and are able to control it with 100% survival and full parasite clearance. SR-A-/- infected in parallel showed no difference in survival or parasitemia during the course of infection (data not shown), again in agreement with the results very recently published by Inoue et al. [17].
###end p 15
###begin p 16
Taken together our data suggests that the lack of SR-A receptors has no influence in the malaria outcome during the blood stages of infection.
###end p 16
###begin title 17
Conclusion
###end title 17
###begin p 18
###xml 82 101 82 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 627 646 627 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 995 996 995 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 82 100 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 627 645 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 934 938 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
###xml 1087 1093 <span type="species:ncbi:9606">humans</span>
The results shown here do not reveal a function of SR-A I and II receptors in the Plasmodium berghei ANKA infection, in the development of CM or parasitemia control. Moreover, these receptors appear not to be required for the establishment of a protective immune response against the malaria liver stages in the well-established model of immunity against RAS. It has been shown that mice deficient in another member of the scavenger receptor family, CD36, have no differences at the liver infection [18]. Moreover, recent experiments with mice deficient in CD36, indicate that this receptor is involved in the sequestration of Plasmodium berghei ANKA to the lung and adipose tissues but not in the development of cerebral malaria [19]. In view of the complex and overlapping functions of different scavenger receptors it is conceivable that the true role of individual receptors is not revealed in experiments with receptor deficient mice unless a specific function of the receptor is analyzed [6]. Whether SR-A receptors do have such specific functions in malaria infections of mice or humans remains to be elucidated.
###end p 18
###begin title 19
Methods
###end title 19
###begin title 20
Infection
###end title 20
###begin p 21
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 78 98 78 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles stephensi </italic>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 326 345 326 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 402 421 402 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 429 439 429 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. yoelii </italic>
###xml 447 448 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 0 18 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 78 97 <span type="species:ncbi:30069">Anopheles stephensi</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 326 344 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 402 420 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 429 438 <span type="species:ncbi:5861">P. yoelii</span>
Plasmodium berghei ANKA sporozoites were obtained from dissection of infected Anopheles stephensi mosquito salivary glands from the IMM insectary production. Male, 7-9 weeks old, SR-A-/- and their control littermate mice generously provided by Dr. T. Kodama (University of Tokyo) [8] were infected by intravenous injection of Plasmodium berghei (2 x 104) sporozoites or by intraperitoneal injection of Plasmodium berghei ANKA or P. yoelii 17 x (106) infected erythrocytes (originally, provided by Dr. A. Waters and C. Janse, Leiden University, or Dr. David Walliker, Edimburgh University, respectively).
###end p 21
###begin title 22
Parasite quantification in the liver
###end title 22
###begin p 23
###xml 256 275 256 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 256 274 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
40 hours post infection with sporozoites livers were removed, homogenized and total RNA was extracted (RNeasy Mini kit Quiagen). cDNA was obtained by reverse transcription (First-strand cDNA synthesis kit, Roche). Real-time PCR, using primers specific for Plasmodium berghei 18S rRNA (5'-AAGCATTAAATAAAGCGAATACATCCTTAC-3' and 5'-GGAGATTGGTTTTGACGTTTATGTG-3'), was used for quantification of parasite load in the livers of mice 40 hours after sporozoite inoculation.
###end p 23
###begin title 24
Immunization protocol
###end title 24
###begin p 25
###xml 82 84 82 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 115 134 111 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 196 198 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 115 133 <span type="species:ncbi:5821">Plasmodium berghei</span>
Immunizations with radition attenuated sorozoites was perfomed by injecting 5 x 104 gamma-irradiated (16,000 rads) Plasmodium berghei ANKA sporozoites followed by challenge (10 days later) with 104 infective sporozoites, both by intravenous injection. Parasite burden in the liver was measured as described in the previous section.
###end p 25
###begin title 26
Following blood stage infection and pathology
###end title 26
###begin p 27
Cerebral complications were monitored by ataxia, paralysis, deviation of the head and convulsions, symptoms leading to coma and death. Blood peripheral parasitemia was determined by counting parasites in Giemsa stained thin blood films.
###end p 27
###begin title 28
Acknowledgements
###end title 28
###begin p 29
###xml 302 306 <span type="species:ncbi:10090">mice</span>
We thank Werner Haas for critically reading this manuscript. MCR supported by Fundacao para a Ciencia e Tecnologia (BD/8435/2002) performed liver and blood stage infections, immunization assays, qPCR assays, data analysis and participated both in the study design and manuscript drafting. SP performed mice genotyping, RNA extractions, blood parasitemia quantification. MF participated in the study design. MMM conceived the study, participated in its design and coordination as well as manuscript drafting. MMM supervises MCR and SP. MMM is a fellow of the EMBO YIP and is a Howard Hughes Medical Institute International Research Scholar. The work was supported by Fundacao para a Ciencia e Tecnologia (Grants POCTI/SAU-MMO/60930/2004 to MMM) and European Science Foundation (Grant EURYI 2004 to MMM). All authors read and approved the final manuscript.
###end p 29
###begin article-title 30
Migration of Plasmodium sporozoites through cells before infection
###end article-title 30
###begin article-title 31
###xml 26 44 <span type="species:ncbi:5821">Plasmodium berghei</span>
Intravital observation of Plasmodium berghei sporozoite infection of the liver
###end article-title 31
###begin article-title 32
Neurological manifestations of falciparum malaria
###end article-title 32
###begin article-title 33
The role of scavenger receptors in the innate immune system
###end article-title 33
###begin article-title 34
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs
###end article-title 34
###begin article-title 35
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale
###end article-title 35
###begin article-title 36
Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS
###end article-title 36
###begin article-title 37
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
###end article-title 37
###begin article-title 38
Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis
###end article-title 38
###begin article-title 39
The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock
###end article-title 39
###begin article-title 40
Quantitative Plasmodium sporozoite neutralization assay (TSNA)
###end article-title 40
###begin article-title 41
###xml 53 58 <span type="species:ncbi:9606">human</span>
Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria
###end article-title 41
###begin article-title 42
###xml 77 95 <span type="species:ncbi:5821">plasmodium berghei</span>
Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei
###end article-title 42
###begin article-title 43
T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages
###end article-title 43
###begin article-title 44
Immunological processes in malaria pathogenesis
###end article-title 44
###begin article-title 45
###xml 68 74 <span type="species:ncbi:10090">murine</span>
Involvement of macrophage scavenger receptors in protection against murine malaria
###end article-title 45
###begin article-title 46
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Short report: role of type I/II scavenger receptors in malarial infection in C57BL/6J mice
###end article-title 46
###begin article-title 47
###xml 0 17 <span type="species:ncbi:5861">Plasmodium yoelii</span>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Plasmodium yoelii sporozoites infect CD36-deficient mice
###end article-title 47
###begin article-title 48
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration
###end article-title 48
###begin title 49
Figures and Tables
###end title 49
###begin p 50
###xml 40 59 40 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lack of SR-A expression does not affect <italic>Plasmodium berghei </italic>liver infection. </bold>
###xml 80 99 80 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 156 175 156 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 220 239 220 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 303 322 303 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 422 441 422 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 517 536 517 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 573 574 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 40 58 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 80 98 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 156 174 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 220 238 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 303 321 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 422 440 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 517 535 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
Lack of SR-A expression does not affect Plasmodium berghei liver infection. (A) Plasmodium berghei quantification in the liver 40 hours post infection with Plasmodium berghei ANKA sporozoites as measured by qRT-PCR. (B) Plasmodium berghei quantification in the liver 40 hours post challenge with 10,000 Plasmodium berghei ANKA sporozoites, in animals previously immunized with a single dose of 50,000 radiation attenuated Plasmodium berghei ANKA sporozoites (RAS), as measured by qRT-PCR. Shown is the mean number of Plasmodium berghei ANKA 18s per HPRT mRNA molecules (x103) +/- standard deviation (n = 4 mice per plot). Experiments were repeated twice.
###end p 50
###begin p 51
###xml 40 59 40 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 0 99 0 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lack of SR-A expression does not affect <italic>Plasmodium berghei </italic>infection and its associated pathology. </bold>
###xml 139 143 139 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 151 155 151 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 176 178 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 178 197 178 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 40 58 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 178 196 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
Lack of SR-A expression does not affect Plasmodium berghei infection and its associated pathology. Survival (A) and parasitemia (B) of SR-A-/- and SR-A+/+ mice infected with 106 Plasmodium berghei ANKA infected red blood cells. Mean +/- standard deviation (n = 4 mice per plot) is shown for parasitemias. Experiment repeated 3 times.
###end p 51

